National Medical Insurance Bureau: The payment of employees' medical insurance units will be implemented in small and medium -sized enterprises in conditions for conditions
Author:Xinhuanet Time:2022.06.18
Xinhua News Agency, Beijing, June 17 (Reporter Peng Yunjia) Chen Jinfu, deputy director of the National Medical Insurance Bureau, said at a routine briefing of the State Council's policy on the 17th that in order to help enterprises' rescue and stabilize, the staged regions with conditions to small, medium and micro enterprises are staged to small, medium and micro enterprises. The implementation time of the implementation of the employee's medical insurance unit is implemented for 3 months, and the amount of capital is expected to pay about 150 billion yuan.
Chen Jinfu said that on the basis of considering the affordability of the medical insurance fund, the regional regions mainly refer to the overall regions of the medical insurance fund for more than 6 months.
"Slowly paying measures are exempted from shackles, and each enterprise does not need to go to the Medical Insurance Office to provide application materials." Chen Jinfu said that at the same time as slow payment, it is required to ensure the treatment of insured personnel. In other words, the level of medical insurance reimbursement during the slow payment period does not decrease, ensuring that it should be guaranteed, enjoyed, reported, and diligently.
He introduced that through big data, the employer's payment recognition can include most of the qualified small, medium and micro enterprises into the scope of policy enjoyment, and enterprises that have not been included can apply according to policy applications. At present, the State Medical Insurance Bureau is investigating specific retracting measures.
In order to actively support the prevention and control of the epidemic, the National Medical Insurance Bureau has allocated a total of 20 billion yuan of special funds, and the cost of treatment of patients with new crown pneumonia is guaranteed.并多轮磋商降低疫苗和核酸检测价格,实现灭活疫苗价格降到每剂20元以下,核酸检测单人单检已降至每人次不超过16元、混检每人次不超过5元、大Scale nucleic acid testing does not exceed 3.5 yuan per person.
- END -
In 2022, the first (enlarged) meeting and intellectual property work leadership group, strong quality city work
On June 14th, the first session of the city's first (enlarged) meeting and intellectual property work leadership group, and the quality city work leadership group meeting was held in 2022, and the spi...
High temperature refresh Wuhan's "face value", bringing the most beautiful "Wuhan Blue"!
Jimu Journalist Song BiotaoIn the past few days, Wuhan's temperature festival has ...